secwatch.observer — SEC 8-K summary
======================================

Issuer:     HAEMONETICS CORP (HAE)
CIK:        0000313143
Form:       8-K
Filed at:   2022-06-16T23:59:59+00:00
Accession:  0000313143-22-000032
Event type: leadership
Sentiment:  neutral
Materiality: 0.30
Item codes: 5.02
LLM model:  deepseek-v4-flash:cloud@v2

EVP & General Counsel Michelle Basil to depart Haemonetics by Oct 31, 2022
--------------------------------------------------------------------------

- Michelle L. Basil, EVP and General Counsel, will transition from Haemonetics effective October 31, 2022.
- She will remain in her role through the Retention Date to ensure a seamless transition while a successor is sought.
- Under the Agreement, she will receive a $500,000 retention bonus if she stays through Oct 31 without resignation or cause termination.
- Her base salary continues unchanged and outstanding equity awards vest through Retention Date; she will not receive FY2023 short-term incentive bonus.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/313143/000031314322000032/0000313143-22-000032-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/313143/000031314322000032/hae-20220611.htm
  HTML page:      https://secwatch.observer/filing/0000313143-22-000032

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer